Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment
Clinical trial NCT02788474 · COMPLETED
Trial details
- NCT number
- NCT02788474
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-09
- Primary completion
- 2017-08-04
- Enrollment
- 347
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.